Healthcare · head to head
OpenMRS vs Techcyte

OpenMRS
Healthcare
Open source electronic medical record platform for low-resource settings, with no vendor and paid implementers instead
- From
- Free
- Rated
- -

Techcyte
Healthcare
AI digital pathology across clinical, veterinary and environmental laboratory disciplines
- From
- On request
- Rated
- -
The short version
- Only OpenMRS has a free tier, so it costs nothing to try first.
- Each has a real cost: OpenMRS there is no vendor and no support contract from OpenMRS itself, so a procurement that requires a named supplier with a service level must instead contract an implementer, and the quality of that implementer determines the outcome more than the software does; Techcyte regulatory status runs the opposite way to what most buyers assume: the products are CE marked and clinically deployed in Europe while several United States offerings including Fusion Parasitology are labelled research use only and not for diagnostic use, so an American laboratory must verify each module individually.
- They diverge on capability: OpenMRS covers Concept dictionary, Techcyte covers Fusion Parasitology Suite.
- Prices and features above were last checked on 1 September 2026.
Where they differ
Only the attributes on which OpenMRS and Techcyte actually diverge.
Identical on both: user rating (Not yet rated), category (Healthcare).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in OpenMRS
- Concept dictionary
- Modular architecture
- Modern front end
- FHIR support
- Offline tolerance
- Patient matching and registration
- Distributions
Only in Techcyte
- Fusion Parasitology Suite
- Cervical cytology
- Haematology
- Urinalysis
- Bacteriology and mycology
- Vetcyte
- Scanner agnostic ingestion
- Remote review
What people use each for
The jobs each tool is most often brought in to do.
OpenMRS
- A ministry of health standardising HIV treatment records across hundreds of facilities where per-patient licensing would be unaffordablenot Techcyte
- A hospital network in a country where no commercial vendor supports the local language, clinical forms or reporting requirementsnot Techcyte
- An NGO running a tuberculosis programme that must report into DHIS2 and needs the clinical record beneath it to be modifiablenot Techcyte
- A health system that wants to own its clinical data model outright rather than depend on a vendor to extend itnot Techcyte
Techcyte
- A clinical laboratory that cannot recruit technologists for high volume manual parasitology screening and needs AI pre screening with human releasenot OpenMRS
- A veterinary reference laboratory processing large volumes of faecal and blood smears that wants Vetcyte to triage the normal casesnot OpenMRS
- A European laboratory that can deploy the CE marked products clinically, which is where Techcyte regulatory position is strongestnot OpenMRS
- An environmental testing laboratory needing consistent microscopy classification across analysts and sitesnot OpenMRS
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
OpenMRS
- There is no vendor and no support contract from OpenMRS itself, so a procurement that requires a named supplier with a service level must instead contract an implementer, and the quality of that implementer determines the outcome more than the software does
- It is a framework rather than a ready product, so a deployment requires clinical content, form design, concept dictionary work and integration before a single patient is registered, and that work is months of skilled effort
- Funding comes largely from donor programmes, which makes the pace of core development dependent on grant cycles rather than on a commercial roadmap, and priorities can shift when a funder does
- Distribution choice, core OpenMRS against Bahmni against Ozone, locks in a different set of components and a different implementer pool, and migrating between distributions later is close to a fresh implementation
- The people cost never goes away: a national deployment needs permanent internal informatics capacity or a permanent support contract, and organisations that budget only the zero licence fee run out of money at the point the system becomes clinically critical
Techcyte
- Regulatory status runs the opposite way to what most buyers assume: the products are CE marked and clinically deployed in Europe while several United States offerings including Fusion Parasitology are labelled research use only and not for diagnostic use, so an American laboratory must verify each module individually.
- Slide scanning for parasitology, haematology and cytology needs multi plane imaging that a histology scanner may not produce, so a laboratory that already owns a scanner often has to buy new hardware, which becomes the biggest line in the project.
- Each discipline is licensed separately, so a laboratory wanting parasitology, urinalysis and haematology assembles three modules and three validation studies rather than buying one platform.
- AI pre screening does not remove the need for a qualified reviewer to release results, so the staffing saving is in review time per slide, not in headcount, and business cases that assume otherwise do not hold.
- Techcyte covers a very wide set of disciplines, which means depth varies between them, and the maturity of a newer module is not the maturity of the parasitology or cytology products that made the company its name.
Pricing, plan by plan
OpenMRS
Free- OpenMRSFree
- Openly licensed, no licence fee and no seat limits
- Community support through forums and the OpenMRS Talk platform
- No support contract available from OpenMRS itself
Techcyte
On request- Techcyte$undefined/year
- Priced per slide or per annual specimen volume by discipline
- Each discipline module licensed separately
- Slide scanning hardware bought separately, not included
Which should you pick?
Choose OpenMRS if
- You need concept dictionary.
- You want to start without paying.
- You work on Linux, Web, Windows.
- You also want modular architecture.
Choose Techcyte if
- You need fusion parasitology suite.
- You also want cervical cytology.
Questions people ask
- Is OpenMRS or Techcyte better?
- Neither clearly leads. OpenMRS starts at Free and Techcyte at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, OpenMRS or Techcyte?
- OpenMRS has a free tier; the other does not. Paid plans start at Free for OpenMRS and On request for Techcyte.
- Does OpenMRS or Techcyte run on more platforms?
- OpenMRS runs on Linux, Web, Windows. Techcyte runs on Web.
- Can I use OpenMRS for free?
- Yes. OpenMRS has a free tier, so you can try it without paying. Techcyte starts at On request.
- What is OpenMRS best used for?
- OpenMRS is most often used for a ministry of health standardising hiv treatment records across hundreds of facilities where per-patient licensing would be unaffordable, a hospital network in a country where no commercial vendor supports the local language, clinical forms or reporting requirements, an ngo running a tuberculosis programme that must report into dhis2 and needs the clinical record beneath it to be modifiable, a health system that wants to own its clinical data model outright rather than depend on a vendor to extend it. Of those, a ministry of health standardising hiv treatment records across hundreds of facilities where per-patient licensing would be unaffordable and a hospital network in a country where no commercial vendor supports the local language, clinical forms or reporting requirements are not what Techcyte is typically brought in for.
- What can OpenMRS do that Techcyte cannot?
- OpenMRS covers Concept dictionary, Modular architecture, Modern front end, FHIR support. Techcyte covers Fusion Parasitology Suite, Cervical cytology, Haematology, Urinalysis.
Answered from the vendors’ own pages
OpenMRS: Who supports OpenMRS if it breaks?
Not OpenMRS itself. Support is bought from implementers such as Mekom Solutions, which offers long-term production service level agreements for OpenMRS, Bahmni and Ozone deployments, or from regional partners.
Techcyte: Is Techcyte FDA cleared?
Not uniformly. Several United States offerings, including the Fusion Parasitology Suite, are labelled research use only and not for diagnostic use in the United States. Check the regulatory status of each specific module for your country before purchase.
OpenMRS: Is it really free?
The software has no licence fee. Hosting, configuration, clinical content, integration and support are the real cost, and they are ongoing.
Techcyte: Can we use it clinically in Europe?
Techcyte solutions are CE marked and clinically deployed across Europe, which is where its regulatory position is strongest. Confirm the current certificate for the specific module.
OpenMRS: What is the difference between OpenMRS, Bahmni and Ozone?
OpenMRS is the core platform. Bahmni and Ozone are distributions that package it with billing, laboratory and inventory components. Choosing a distribution constrains your implementer options.
Techcyte: Does it eliminate the need for a technologist?
No. AI pre screens and prioritises, but a qualified reviewer still releases results. The saving is in review time per slide.
OpenMRS: Does it support FHIR?
Yes. FHIR support is the standard route for integrating laboratory, pharmacy and national reporting systems.
Techcyte: Do we need a specific scanner?
Techcyte works with several scanner vendors, but disciplines such as parasitology and haematology need multi plane imaging that many histology scanners cannot produce, so confirm hardware compatibility early.
Related pages
Other head to heads
- OpenMRS vs GNU Health
- OpenMRS vs DHIS2
- OpenMRS vs Athenahealth
- OpenMRS vs Cerner
- OpenMRS vs Bahmni
- OpenMRS vs OpenClinica
- OpenMRS vs Open Dental
- OpenMRS vs Ambra Health
- OpenMRS vs Visage Imaging
- OpenMRS vs Included Health
- OpenMRS vs Halaxy
- OpenMRS vs Meru Health
- OpenMRS vs Philips IntelliSpace PACS
- OpenMRS vs PioneerRx
- OpenMRS vs Rad AI
- OpenMRS vs Aidoc
- OpenMRS vs Annalise.ai
- OpenMRS vs Rx30
- OpenMRS vs PathAI
- OpenMRS vs Lunit
- OpenMRS vs Ibex Medical Analytics
- OpenMRS vs Sysmex
- OpenMRS vs Paige
- OpenMRS vs Sectra
- OpenMRS vs Gleamer
- OpenMRS vs Therapixel
- OpenMRS vs Beckman Coulter DxONE
- OpenMRS vs Koa Health
- OpenMRS vs Fullscript
- OpenMRS vs Cerner PowerWorks
- OpenMRS vs ChiroTouch
- OpenMRS vs Doctolib
- OpenMRS vs Doximity
- OpenMRS vs eClinicalWorks
- OpenMRS vs eClinicalWorks Prime
- Techcyte vs GNU Health
- Techcyte vs DHIS2
- Techcyte vs Athenahealth
- Techcyte vs Cerner
- Techcyte vs Bahmni
- Techcyte vs OpenClinica
- Techcyte vs Open Dental
- Techcyte vs Ambra Health
- Techcyte vs Visage Imaging
- Techcyte vs Included Health
- Techcyte vs Halaxy
- Techcyte vs Meru Health
- Techcyte vs Philips IntelliSpace PACS
- Techcyte vs PioneerRx
- Techcyte vs Rad AI
- Techcyte vs Aidoc
- Techcyte vs Annalise.ai
- Techcyte vs Rx30
- Techcyte vs PathAI
- Techcyte vs Lunit
- Techcyte vs Ibex Medical Analytics
- Techcyte vs Sysmex
- Techcyte vs Paige
- Techcyte vs Sectra
- Techcyte vs Gleamer
- Techcyte vs Therapixel
- Techcyte vs Beckman Coulter DxONE
- Techcyte vs Koa Health
- Techcyte vs Fullscript
- Techcyte vs Cerner PowerWorks
- Techcyte vs ChiroTouch
- Techcyte vs Doctolib
- Techcyte vs Doximity
- Techcyte vs eClinicalWorks
- Techcyte vs eClinicalWorks Prime
